Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2025-12-26 @ 3:52 AM
Study NCT ID:
NCT06394518
Status:
COMPLETED
Last Update Posted:
2024-05-01
First Post:
2024-04-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants
Sponsor:
TenNor Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-24
Completion Date Type:
ACTUAL
First Submit Date:
2024-04-27
First Submit QC Date:
None
Study First Post Date:
2024-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-27
Last Update Post Date:
2024-05-01
Last Update Post Date Type:
ACTUAL